Effects of Artemisinin and Its Derivatives on Oral Microbes

ZHU Cheng-guang, REN Biao, CHENG Lei, ZHOU Xue-dong

Abstract

The oral environment provides suitable conditions for the colonization of various microorganisms. However, the oral microbials could be the initial factors of some kinds of oral infectious diseases, therefore the treatment against oral microbial pathogens has become an effective strategy. Artemisinin, a kind of sesquiterpene lactone extracted from Traditional Chinese Medicine Artemisia annua L, is the first-line therapy to treat tertian malaria, subtertian malaria and anti-chloroquine malaria for its high efficiency and low toxicity. In recent years, artemisinin and its derivatives have also been proven to be effective against bacteria, fungi, viruses, parasites, and tumors, some of which are closely related to oral diseases. In this review, we summarize the potential effects of artemisinin and its derivatives on oral microorganism by analyzing previous research and latest progress to provide the evidence for further improvement, and look forward to the new research directions. Further studies are needed to improve existing technologies and standards to clarify the effects of artemisinin and its derivatives on microorganisms with controversial effects, to expand the detection of microorganisms associated with oral infectious diseases, and to clarify the interaction with existing antifungal agents in the field of antifungal diseases. In addition, in the study of anti-oral infectious diseases, artemisinin and its derivatives’ administration scheme, potential drug interactions, toxic and side effects and other aspects are necessary conditions for further research, which is also a new direction of research. With the maturity of the production process, the improvement of relevant research and the potential demand for the treatment of oral infectious diseases, artemisinin and its derivatives have a broad prospect in the field of oral microorganisms, and provide a new opportunity for the research and development of oral drugs.

 

Keywords: Artemisinin, Artemisinin derivatives, Oral microbes, Anti-Bacterial agents, Antifungal agents (TCD)

 

Full Text:

PDF


References


VERMA D， GARG P K， DUBEY A K. Insights into the human oral microbiome. Arch Microbiol，2018，200(4): 525–540.

MOSADDAD S A， TAHMASEBI E， YAZDANIAN A， et al. Oral microbial biofilms: an update. Eur J Clin Microbiol Infect Dis，2019， 38(11): 2005–2019.

GARCIA S S， BLACKLEDGE M S， MICHALEK S， et al. Targeting of Streptococcus mutans biofilms by a novel small molecule prevents dental caries and preserves the oral microbiome. J Dent Res，2017，96(7): 807–814.

LEE L W， LEE Y L， HSIAO S H， et al. Bacteria in the apical root canals of teeth with apical periodontitis. J Formos Med Assoc，2017，116(6): 448–456.

TORRES P J， THOMPSON J， MCLEAN J S， et al. Discovery of a novel periodontal disease-associated bacterium. Microb Ecol，2019，77(1): 267–276.

LEWIS M， WILLIAMS D W. Diagnosis and management of oral candidosis. Br Dent J，2017，223(9): 675–681.

NAGLIK J R， KONIG A， HUBE B， et al. Candida albicans-epithelial interactions and induction of mucosal innate immunity. Curr Opin Microbiol，2017，40: 104–112.

JIA G， ZHI A， LAI P， et al. The oral microbiota—a mechanistic role for systemic diseases. Br Dent J，2018，224(6): 447–455.

NAZIR M A. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci，2017，11(2): 72–80.

WHITE N J. Qinghaosu (artemisinin): the price of success. Science，2008， 320(5874): 330–334.

MESHNICK S R. Artemisinin: mechanisms of action, resistance and toxicity. Int J Parasitol，2002，32(13): 1655–1660.

CUI L， SU X. Discovery, mechanisms of action and combination therapy of artemisinin. Expert Rev Anti Infect Ther，2009，7(8): 999–1013.

TU Y. The discovery of artemisinin (Qinghaosu) and gifts from Chinese Medicine. Nat Med，2011，17(10): 1217–1220.

WATTS G. Nobel awarded to discoverers of ivermectin and artemisinin. BMJ，2015，351: h5352[2020-06-15]. https://doi.org/10.1136/bmj.h5352. SHEN B. A new golden age of natural products drug discovery. Cell， 2015，163(6): 1297–1300.

HO W E， PEH H Y， CHAN T K， et al. Artemisinins: pharmacological actions beyond anti-malarial. Pharmacol Ther，2014，142(1): 126–139.

SLEZAKOVA S， RUDA-KUCEROVA J. Anticancer activity of artemisinin and its derivatives. Anticancer Res，2017，37(11): 5995–6003.

APPALASAMY S， LO K Y， CH'NG S J， et al. Antimicrobial activity of artemisinin and precursor derived from in vitro plantlets of Artemisia annua L. Biomed Res Int，2014，2014: 215872[2020-06-15]. http://dx.doi.org/10.1155/2014/215872.

DAS S， CZUNI L， BALO V，et al. Cytotoxic action of artemisinin and scopoletin on planktonic forms and on biofilms of Candida Species. Molecules，2020，25(3):476[2020-06-15]. https://doi.org/10.3390/molecules25030476.

KRISHNAN K， CHEN T， PASTER B J. A practical guide to the oral microbiome and its relation to health and disease. Oral Diseases，2017， 23(3): 276–286.

WANG Y， REN B， ZHOU X， et al. Growth and adherence of Staphylococcus aureus were enhanced through the PGE2 produced by the activated COX-2/PGE2 pathway of infected oral epithelial cells. PloS One， 2017， 12(5): e0177166[2020-06-15]. https://doi.org/10.1371/journal.pone.0177166.

CHEN Y， LAI L， ZHANG H， et al. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis. World J Gastroenterol，2016，22(10): 2949–2959.

SLADE D， GALAL A M， GUL W， et al. Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers. Bioorg Med Chem，2009，17(23): 7949–7957.

LOHR G D， HOLLABAUGH B， WATERS P， et al. Methicillin-resistant Staphylococcus aureus and antibiotic use in septorhinoplasty: case report and review of literature. Oral Surg Oral Med Oral Pathol Oral Radiol， 2017， 123(6): e177-e181[2020-05-09]. https://doi.org/10.1016/j.oooo. 2017.01.002.

VELLAPPALLY S， DIVAKAR D D， AL KHERAIF A A， et al. Occurrence of vancomycin-resistant Staphylococcus aureus in the oral cavity of patients with dental caries. Acta Microbiol Immunol Hung， 2017，64(3): 343–351.

GOSWAMI S， BHAKUNI R S， CHINNIAH A， et al. Anti Helicobacter pylori potential of artemisinin and its derivatives. Antimicrob Agents Chemother，2012，56(9): 4594–4607.

LIN L， MAO X， SUN Y， et al. Antibacterial mechanism of artemisinin/beta-cyclodextrins against methicillin-resistant Staphylococcus aureus (MRSA). Microb Pathog，2018，118: 66–73.


Refbacks

  • There are currently no refbacks.